Protection against stroke with glucagon-like peptide-1 receptor agonists: a comprehensive review of potential mechanisms

Abstract Several randomized controlled trials have demonstrated the benefits of glucagon-like peptide-1 receptor agonists (GLP-1RAs) on ischemic stroke in patients with diabetes. In this review, we summarize and discuss the potential mechanisms of stroke protection by GLP-1RAs. GLP-1RAs exert multip...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Bruno Vergès, Victor Aboyans, Denis Angoulvant, Pierre Boutouyrie, Bertrand Cariou, Fabien Hyafil, Kamel Mohammedi, Pierre Amarenco
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	BMC 2022-11-01
Sarja:	Cardiovascular Diabetology
Aiheet:	Stroke Glucagon-like peptide-1 receptor agonists GLP-1 Neuroprotection Mechanisms
Linkit:	https://doi.org/10.1186/s12933-022-01686-3
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!